Skip to main content
Explore URMC

Megan A. Baumgart, M.D.

Contact Information

Phone Numbers

Appointment: (585) 275-5823

Administrative: (585) 275-9319

Fax: (585) 273-5761

URMFGA member of the University of Rochester Medical Faculty Group

groupAn Accountable Health Partner

assignmentAccepting New Patients

Faculty Appointments

Patient Care Setting



I chose the field of oncology because I want to help patients through one of the most difficult experiences a person can have.

Cancer treatment requires a team approach involving the patient, medical oncologist, nurses and support staff, as well as other medical teams such as radiation oncology and surgery who are often part of a patient's care. I work with patients to help them understand the overall treatment plan – especially the role of chemotherapy in the treatment of their disease – and support them throughout the course of treatment.

I am optimistic about the future of cancer treatment and want to work towards finding new and better treatment strategies for lung and head and neck cancers through the development of our clinical trials program. We currently have several clinical trials evaluating the role of immunotherapy for the treatment of metastatic head and neck cancers open for enrollment, as well as other clinical trials focused on answering important questions regarding the management of these diseases.

Conditions I Treat

- Small cell lung cancer
- Non-small cell lung cancer
- Head and neck cancers
- Thyroid cancer



  • Internal Medicine - American Board of Internal Medicine
  • Medical Oncology - American Board of Internal Medicine


MD | Albany Medical College of Union University

Post-doctoral Training & Residency

07/01/2011 - 06/30/2014
Fellowship in Medical Oncology at Yale New Haven Hospital

07/01/2008 - 06/30/2010
Residency in Internal Medicine at Rhode Island Hospital

06/20/2007 - 06/30/2008
Internship in Internal Medicine at Rhode Island Hospital

VIEW ALL expand_more


2019 - Present
Early Career Women Faculty Leadership Development Seminar
Sponsor: AAMC Application Selection Committee

Annual Award for Outstanding Oncology Research
Sponsor: Yale University Medical Oncology and Hematology Fellowship
Location: New Haven, CT

Albany Medical College- Distinction in Biomedical Ethics
Location: Albany, NY

VIEW ALL expand_more


Journal Articles

Baumgart, M.; Bazhenova, L.; Haggstrom, D.; Baranda, J.; Belani, C. "PUB031 PRIMAL: A Phase 1b Study of PEGPH20 plus Docetaxel in Patients with Previously Treated Hyaluronan (HA)-High Advanced NSCLC". Journal of Thoracic Oncology. 2017; 12(1): S1465.

Abu-Khalaf MM, Baumgart MA, Gettinger SN, Doddamane I, Tuck DP, Hou S, Chen N, Sullivan C, Lezon-Geyda K, Zelterman D, Hatzis C, Deshpande H, Digiovanna MP, Azodi M, Schwartz PE, Harris LN. "Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin-bound paclitaxel in patients with advanced solid tumors." Cancer.. 2015 Jun 1; 121(11):1817-26. Epub 2015 Feb 03.

Baumgart, M. "New molecular targets on the horizon in non-small cell lung cancer". American Journal of Hematology and Oncology. 2015; 11(6): 10-13.